K. Boeke

immunosuppressant SDZ-RAD Successful treatment of acute, ongoing rat lung allograft rejection with the novel

G. Berry, U. Christians, R. Morris, 2013 .

Successful treatment of acute, ongoing rat lung allograft rejection with the novel immunosuppressant SDZ-RAD.

G. Berry, U. Christians, R. Morris, 2000, The Annals of thoracic surgery.

Suppression of acute rejection in allogeneic rat lung transplantation: a study of the efficacy and pharmacokinetics of rapamycin derivative (SDZ RAD) used alone and in combination with a microemulsion formulation of cyclosporine.

G. Berry, U. Christians, R. Morris, 1999, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Development of obliterative bronchiolitis after allogeneic rat lung transplantation: implication of acute rejection and the time point of treatment.

U. Spranger, S. Hirt, H. Wottge, 1999, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Airway Goblet Cells and Respiratory Epithelial Injury in an Animal Model of Obliterative Airways Disease (OAD)

R. Morris, T. Ikonen, A. Dosanjh, 2001, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Coadministration of neoral and the novel rapamycin analog, SDZ RAD, to rat lung allograft recipients: potentiation of immunosuppressive efficacy and improvement of tolerability of staggered versus simultaneous treatment.

G. Berry, U. Christians, L. Benet, 1999, Transplantation.

VIRAL SERINE PROTEINASE INHIBITOR (SERP-1) EFFECTIVELY DECREASES THE INCIDENCE OF GRAFT VASCULOPATHY IN HETEROTOPIC HEART ALLOGRAFTS1

G. Berry, R. Morris, B. Hausen, 2001 .

VIRAL SERINE PROTEINASE INHIBITOR (SERP‐1) EFFECTIVELY DECREASES THE INCIDENCE OF GRAFT VASCULOPATHY IN HETEROTOPIC HEART ALLOGRAFTS.: Abstract# 895 Poster Board #‐Session: P152‐III

G. Berry, R. Morris, B. Hausen, 2000, Transplantation.

Pharmacodynamics of Mycophenolate Mofetil after Heart Transplantation: New Mechanisms of Action and Correlations with Histologic Severity of Graft Rejection

J. Gummert, M. Barten, R. Morris, 2002, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Anti-rejection prophylaxis by blocking selectin dependent cell adhesion after rat allogeneic and xenogeneic lung transplantation.

A. Haverich, Prof. Dr. med. Gustav Steinhoff, M. L. Phillips, 1997, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Potentiation of immunosuppressive efficacy by combining the novel leflunomide analog, HMR 279, with microemulsion cyclosporine in a rat lung transplant model.

G. Berry, U. Christians, J. Gummert, 1999, Transplantation.

The lung as a source and a target organ for T- and B-lymphocytes.

Prof. Dr. med. Gustav Steinhoff, R. Pabst, J. Westermann, 1997, American journal of respiratory cell and molecular biology.

Induction of endothelial adhesion molecules by rat cytomegalovirus in allogeneic lung transplantation in the rat.

A. Haverich, Prof. Dr. med. Gustav Steinhoff, C. Bruggeman, 1995, Scandinavian journal of infectious diseases. Supplementum.

Sustained suppression of peripheral blood immune functions by treatment with mycophenolate mofetil correlates with reduced severity of cardiac allograft rejection.

R. Morris, T. van Gelder, M. Billingham, 2004, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.